In this week’s issue:
- Faculty of Medicine – Spring Start Up Funds (reminder)
- The International Society for Heart & Lung Transplantation – ISHLT/Bayer Pulmonary Hypertension Research Grant Award(reminder)
- Society for the Advancement of Blood Management – Haemonetics Research Starter Grant(reminder)
- Lupus Research Institute – 2014 Distinguished Innovator Awards
- Fahs-Beck Fund for Research and Experimentation – Faculty/Post-Doctoral Grant Program (Fahs-Beck Fellows)(reminder)
Awards and Honours:
- National Foundation for Cancer Research – 2015 Szent-Györgyi Prize for Progress in Cancer Research(reminder)
- Centre for Blood Research Seminar Series – A novel pathway regulating macrophage functions in atherosclerosis
Deadline: May 30, 2014
The Faculty of Medicine has funds available for two awards of $5000. Applicants must be in the first two years of a full-time appointment as Assistant Professor or higher, or a Clinical faculty appointment as Clinical Assistant Professor or higher, in the Faculty of Medicine at the University of British Columbia. Previous awardees of UBC Faculty of Medicine Spring Start Up Funds, and applicants who have received $200,000 or more in Start Up Funds are ineligible.
The funds can be used for the following: Research equipment, research supplies and/or research services (e.g. cost recovery payments to core equipment) and research support salaries (e.g. technical personnel).
Please visit our website for more information.
Deadline: June 2, 2014
The International Society for Heart and Lung Transplantation is a multidisciplinary professional organization dedicated to improving the care of patients with advanced heart or lung disease via research, education, and advocacy.
ISHLT is accepting applications for the 2014 ISHLT/Bayer Pulmonary Hypertension Research Grant, an annual award aimed at furthering the scientific understanding of pulmonary hypertension, with the ultimate goal of improving patient’s lives. One $100,000 grant ($50,000 per year for two years) will be awarded to an ISHLT member for a research project that investigates a relevant clinical or translational science question in pulmonary hypertension (PH), irrespective of the PH subtype.
For further details, please visit the ISHLT website.
Deadline: July 1, 2014
The SABM-Haemonetics Research Starter Grant is intended to advance the field of patient blood management by supporting a young investigator who intends to study methods of promoting blood conservation. This one-year, $20,000 grant provides starter funding to further scientific inquiry and clinical knowledge in the field of patient blood management. Preference will be given to junior faculty who will be advised by an experienced mentor. It is anticipated that the funded study will generate results that can be used as pilot data or preliminary findings to support future grant applications focused on methods to improve blood management and to promote blood conservation. It is expected that all applicants will be members of SABM, or will become members of SABM for at least one year.
For additional details, please visit the SABM website.
Deadline: July 31, 2014
The Lupus Research Institute (LRI) invites applications for its Distinguished Innovator Awards, a global program that will provide outstanding scientists with substantial support for up to four years to conduct novel research into the fundamental causes of lupus and so provide new directions toward a cure or prevention.
Advances across many disciplines have led to novel treatments that aim to suppress the manifestations of lupus. Yet few interventions are being developed that seek to reverse or prevent the disease. LRI Distinguished Innovators will address this gap by pioneering research into the fundamental, causative pathways of lupus.
In pursuit of this goal, the LRI welcomes novel, hypothesis- or discovery-driven proposals in human and/or animal model based lupus research. The research proposal must aim to uncover the fundamental causes of lupus and present a compelling vision of how the discovery would lay the groundwork for a potential cure, prevention, or highly effective therapy.
The expert review panel will judge applications primarily on the novelty and potential of the research proposal, and the strengths and track record of the investigator. Emphasis will be on the rationale for the hypothesis rather than the amount of preliminary data. Continuations of long-term research projects will not be considered.
Successful applicants will be outstanding investigators who have demonstrated creativity and productivity in their field of research. We encourage applications from investigators in diverse disciplines including, but not limited to, immunology, genetics, molecular-, cell- and systems biology. Scientists who have not previously worked in lupus are encouraged to apply, as are researchers working outside the US. Applicants must hold a position at an academic institution.
Annual funding of up to $250,000 per year, for a term of up to four years, will be awarded for approved projects. We anticipate that no more than four Distinguished Innovator Awards will be made in 2014. The full grant application, including a research plan of no more than six pages is due by July 31, 2014.
For additional details, please visit http://www.lupusresearchinstitute.org/2014-distinguished-innovator-awards.
Deadline: November 1, 2014
Grants of up to $20,000 are available to help support the research of faculty members or post-doctoral researchers affiliated with non-profit human service organizations in the United States and Canada. Areas of interest to the Fund are: studies to develop, refine, evaluate, or disseminate innovative interventions designed to prevent or ameliorate major social, psychological, behavioral or public health problems affecting children, adults, couples, families, or communities, or studies that have the potential for adding significantly to knowledge about such problems. The research for which funding is requested must focus on the United States or Canada or on a comparison between the United States or Canada and one or more other countries.
For more details, please visit the Fahs-Beck website.
AWARDS AND HONOURS:
Deadline: September 30, 2014
The National Foundation for Cancer Research is accepting nominations for the 2015 Szent-Györgyi Prize for Progress in Cancer Research.
The annual prize, named in honor of Albert Szent-Györgyi, Nobel Laureate and co-founder of NFCR, is awarded to an outstanding researcher whose scientific achievements have expanded our understanding of cancer and whose discoveries have made possible new approaches to preventing, diagnosing, and/or treating cancer.
Nominations may be made by individuals from the research community, industry, government, and other organizations that are sufficiently familiar with the research accomplishments and contributions of the nominee. Self-nominations will not be accepted. Candidates must have made an original discovery or breakthrough in scientific understanding that has led to better prevention, earlier diagnosis, or new treatments for patients with cancer.
The prize recipient will be honored at a formal dinner and award ceremony and will receive a $25,000 cash prize. In addition, the recipient will lead the next Szent-Györgyi prize committee as honorary chair.
Please visit the NFCR website for further information and nomination details.
Centre for Blood Research Seminar Series – A novel pathway regulating macrophage functions in atherosclerosis
Date & Time: May 28, 2014, 12-1pm
Location: LSC 3, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver
Dr. Vince Duronio
Director, Experimental Medicine Graduate Program
Department of Medicine